INSTITUTO DE INVESTIGACIÓN BIOMÉDICA DE SALAMANCA
Instituto
Vancouver General Hospital
Vancouver, CanadáPublicaciones en colaboración con investigadores/as de Vancouver General Hospital (7)
2023
-
Symptomatic vs. non-symptomatic device-related thrombus after LAAC: a sub-analysis from the multicenter EUROC-DRT registry
Clinical Research in Cardiology, Vol. 112, Núm. 12, pp. 1790-1799
2022
-
Clinical and echocardiographic risk factors for device-related thrombus after left atrial appendage closure: an analysis from the multicenter EUROC-DRT registry
Clinical Research in Cardiology, Vol. 111, Núm. 11, pp. 1276-1285
2021
-
Device-Related Thrombus After Left Atrial Appendage Closure: Data on Thrombus Characteristics, Treatment Strategies, and Clinical Outcomes From the EUROC-DRT-Registry
Circulation: Cardiovascular Interventions, Vol. 14, Núm. 5, pp. E010195
-
Impact of Bacillus Calmette-Gue´rin (BCG) vaccination on postoperative mortality in patients with perioperative SARS-CoV-2 infection
BJS Open
-
Machine learning risk prediction of mortality for patients undergoing surgery with perioperative SARS-CoV-2: The COVIDSurg mortality score
British Journal of Surgery, Vol. 19, Núm. 4
2017
-
Incidence and Clinical Impact of Device-Associated Thrombus and Peri-Device Leak Following Left Atrial Appendage Closure With the Amplatzer Cardiac Plug
JACC: Cardiovascular Interventions, Vol. 10, Núm. 4, pp. 391-399
2013
-
Phase Ib study of panobinostat and bortezomib in relapsed or relapsed and refractory multiple myeloma
Journal of Clinical Oncology